Cell Therapy Equipment For Medical Drugs
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat pleural mesothelioma and non-small-cell lung ...
-
based in USA
Gain is utilizing its Site-Directed Enzyme Enhancement Therapy (See-Tx™) platform to guide misfolded enzymes back into their proper shape in order to treat a range of diseases. ...
-
Manufactured by Mersana Therapeuticsbased in USA
Immunosynthen is our novel immunostimulatory ADC platform designed to take ADCs beyond traditional cytotoxic drugs to targeted stimulation of the innate immune system. Through the safe and efficient delivery of a novel immunomodulatory STING agonist, ADCs created with our Immunosynthen platform have the potential to address the challenges of efficacy, delivery and tolerability. Stimulator of ...
-
Manufactured by CytomX Therapeutics, Inc.based in USA
Probody therapeutics are designed to outsmart cancer by exploiting the unique conditions of the tumor microenvironment to more effectively localize treatment to the tumor, while limiting activity in healthy tissues. These novel therapies are designed to take advantage of high levels of protease activity in the tumor microenvironment. Their target-binding regions are masked to limit activity ...
-
Manufactured by Genenta Sciencebased in ITALY
Temferon™ is a lenti-virus based hematopoietic stem progenitor cell immuno-gene therapy enabling controlled and targeted interferon-α expression within cancers. Biologically delivered via engineered tumor infiltrating monocytes (Tie2 expressing monocytes – TEMs), Temferon™ generates immune responses to any TEMs positive tumors. As such the biological readouts and safety of ...
-
Manufactured by Caladrius Biosciences, Inc.based in USA
The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the human body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ...
-
Manufactured by Vascugen Inc.based in USA
Development of complex iPSC-based therapeutics benefits from an engineering mindset. Each layer of the development and manufacturing process is considered part of the ‘Full Stack’ that leads to finished product. An integrated stepwise approach improves the probability of arriving at the right therapeutic candidate and reduces downstream risks to manufacturing and delivery to the ...
-
Manufactured by IN8Bio Inc.based in USA
INB-100, our DeltEx Allo, is an allogeneic product candidate, initially developed for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation (HSCT). This is the first clinical trial of an expanded and activated allogeneic gamma delta T cell ...
-
Manufactured by Editas Medicinebased in USA
Genomic medicine is a developing field of medical research that harnesses recent advances in genetics to develop new medicines for diseases. In fact, we are at an inflection point where we are seeing the first real genomic medicines emerge to help patients. Advances in the scientific fields of cell therapy and gene therapy have paved the way for the success of gene editing, which in turn is now ...
-
Manufactured by BlueRock Therapeuticsbased in USA
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. Those who have suffered a heart ...
-
Manufactured by Lineage Cell Therapeutics, Inc.based in USA
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction worth up to $670 ...
-
based in USA
Natural killer (NK) cells, as their name implies, play an important role in ridding the body of cancer and viruses. NK cells are emerging as an increasingly important cell type for therapeutic development. Solid tumors are particularly challenging to treat and CAR-T cells have largely underperformed in the solid tumor setting. NK cells, however, inherently target both primary solid tumors and ...
-
Manufactured by Altucell, Inc.based in USA
Encapsulated cell therapy is an emerging area of biopharmaceutical research that aims to unleash the therapeutic potential of cells to treat serious diseases without the need for immunosuppression. Altucell has developed patented, proprietary engineered cells that are combined with a patented encapsulation technology to create effective ...
-
Manufactured by ELITechGroupbased in FRANCE
Epstein-Barr Virus (EBV) is a widespread herpesvirus, generally asymptomatic or sometimes responsible for mild infection like mononucleosis. After solid organ or hematopoietic stem cell transplant, EBV reactivation is a common cause of malignant transformation, called Post-Transplant Lymphoproliferative Disorder “PTLD”. EBV viral load monitoring is important to diagnose, and monitor ...
-
Manufactured by Charter Medical, LLCbased in USA
Freeze-Pak STS (FP-STS) Storage and Transport Solution Bio-Containers are designed for ultra-low temperature frozen storage and transport applications. FP-STS single-use containers offer robust performance to -80°C while the Freeze-Pak film itself is rated to temperatures as low as -196°C. FP-STS containers are suitable for long-term storage of cellular and non-cellular materials. The ...
-
Manufactured by RepliCel Life Sciencesbased in CANADA
RCT-01 is a proprietary autologous cell therapy being developed to treat chronically damaged tendons. * *This product is currently in clinical testing and not yet commercially available. RCT-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
-
Manufactured by Hemogenyx Pharmaceuticals plcbased in UNITED KINGDOM
Hemogenyx Pharmaceuticals has constructed Chimeric Antigen Receptor (CAR) programmed T cells, termed HEMO-CAR-T, for the potential treatment of Acute Myeloid Leukemia (AML). HEMO-CAR-T is made using Hemogenyx’s proprietary humanised monoclonal antibody against a target on the surface of AML ...
-
Manufactured by AGC Biologicsbased in USA
AGC Biologics develops and manufactures Lenti and Retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. Our quality systems, GMP manufacturing scale and regulatory qualification allow us to meet both clinical and commercial demand. Moreover, our scale down ...
-
Manufactured by Biocardia, Inc.based in USA
The investigational CardiAMP™ Cell Therapy is designed to be a comprehensive biotherapeutic heart failure solution, incorporating: a proprietary molecular diagnostic to characterize the potency of a patient’s own bone marrow cells and determine if they are an optimal candidate for therapy. a point of care processing platform to prepare cells at the patient’s bedside. an ...
-
Manufactured by GC Therapeutics Inc.based in USA
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you